跳至主要内容
临床试验/ACTRN12616000886482
ACTRN12616000886482终止未知

Randomised trial aiming to prevent development of depression and improve quality of life in individuals with dementia (Alzheimer’s disease) through a novel Cognitive Bias Modification intervention.

WA Centre for Health and Ageing0 个研究点目标入组 10 人开始时间: 2016年7月6日最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • The inclusion criteria will be;
  • * Diagnosis of major neurocognitive disorder due to probable Alzheimer's disease according to DSM-5 criteria
  • * Mini-Mental State Examination (MMSE) score of greater than or equal to 15
  • * Neuropsychiatric Inventory (NPI) depression domain score of 1 (i.e. no depression)
  • * Availability of a close and reliable informant
  • * Fluent in written and spoken English

排除标准

  • We will exclude individuals who;
  • * Have a medical condition that is likely to compromise their ability to complete the required activities of the study (e.g. severe sensory impairment)
  • * Consume alcohol in excess of 28 standard drinks per week
  • * Have no health practitioner who can provide ongoing clinical care
  • * Have a contra-indication to MRI (MRI sub-group only)
  • * Decline or are unable to provide informed consent.

研究者

发起方
WA Centre for Health and Ageing

相似试验